Tomorrow edition interviews Peter Schmidt, Ph.D., is Senior Vice President, Chief Research & Clinical Officer, at the Parkinson’s Foundation. Dr. Schmidt discusses selective vulnerability in PD, replicating the disease in a lab and discusses PD clinical trial processes.
Tomorrow Edition: Interview With Clinical Trial Expert Dr. Peter Schmidt
A study led by Dr. Robert A. Hauser from the Parkinson’s Disease and Movement Disorders Center at the University of South Florida, a Center of Excellence, proved that participants who took an MAO-B inhibitor for a longer period experienced slower clinical decline.
Dr. Michael Okun, Medical Director and Parkinson’s Disease Foundation’s Dr. Beth Vernaleo discuss recommendations for managing cognitive problems in PD.
Functional imaging data supports improved cognition in people with PD after receiving cognitive rehabilitation, according to a study released at the 1st Pan American Parkinson’s and Movement Disorders Congress. NPF division’s Dr. Peter Schmidt is quoted.
Carolyn Gloudemans shares her my PD story and how Moving Day® North LA motivated her to get moving.
Honor focuses on building technology and a new business model that empowers humans with technology platform leveraging machine learning to uniquely match a care professional’s skills with the needs of specific clients.
Western New York chapter hosted its third annual Parkinson's ice skating party. The free event provided participants with ice bikes, giving people with PD the chance to skate.
In an interview with a national radio network that aired three times, CEO John Lehr discusses the importance of raising awareness of Parkinson’s.
Dr. Michael S. Okun, national medical director of the Parkinson's Foundation, comments on antipsychotics and seniors with dementia: “Though there is an important role for these drugs in this special population, they should be used cautiously."
CEO John Lehr shares his vision for the organization and passion for the cause.
In this article about how to find cutting-edge care, Michael Okun, M.D., National Medical Director and John Andrejack, Ed.D., Research Advocate, share their perspectives.